Sihuan Pharmaceutical Holdings Group Ltd. (HKG:0460)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Medical Aesthetic Products	744.22M	449.91M	149.78M	398.95M	26.87M
Medical Aesthetic Products Growth	65.42%	200.38%	-62.46%	1384.92%	-
Innovative Medicine and Other Medicine	109.67M	36.77M	165.71M	105.11M	452.61M
Innovative Medicine and Other Medicine Growth	198.24%	-77.81%	57.65%	-76.78%	-
Generic Medicine	1.10B	1.40B	1.97B	2.60B	2.20B
Generic Medicine Growth	-21.41%	-29.01%	-24.16%	18.19%	-
Elimination of Intersegment Sales	-52.08M	-24.99M	-104.80M	-63.81M	-213.44M
Total	1.90B	1.86B	2.18B	3.04B	2.46B
Total Growth	2.18%	-14.70%	-28.21%	23.30%	-14.39%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
United States of America	12.56M	13.79M	14.41M	-	-
United States of America Growth	-8.89%	-4.28%	-	-	-
Mainland China	1.89B	1.85B	2.17B	3.04B	2.46B
Mainland China Growth	2.26%	-14.77%	-28.69%	23.30%	-14.39%
Total	1.90B	1.86B	2.18B	3.04B	2.46B
Total Growth	2.18%	-14.70%	-28.21%	23.30%	-14.39%

Source: S&P Global Market Intelligence.